Compare VKTX & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | NATL |
|---|---|---|
| Founded | 2012 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.0B |
| IPO Year | 2014 | 2023 |
| Metric | VKTX | NATL |
|---|---|---|
| Price | $35.08 | $43.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $88.00 | $45.60 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.98 |
| EPS | N/A | ★ 2.14 |
| Revenue | N/A | ★ $4,354,000,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ N/A | $20.44 |
| Revenue Growth | N/A | ★ 0.86 |
| 52 Week Low | $18.92 | $22.30 |
| 52 Week High | $43.15 | $48.50 |
| Indicator | VKTX | NATL |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 53.05 |
| Support Level | $33.65 | $42.03 |
| Resistance Level | $36.23 | $48.50 |
| Average True Range (ATR) | 1.98 | 0.96 |
| MACD | -0.07 | -0.18 |
| Stochastic Oscillator | 77.05 | 61.62 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.